Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27,971 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study.
Wang K, Ren Y, Li H, Zheng K, Jiang J, Zou T, Ma B, Li H, Liu Q, Ou J, Wang L, Wei W, He J, Ren G. Wang K, et al. Among authors: jiang j. PLoS One. 2016 Mar 31;11(3):e0152312. doi: 10.1371/journal.pone.0152312. eCollection 2016. PLoS One. 2016. PMID: 27031236 Free PMC article. Clinical Trial.
Clinicopathologic Factors Related to the Histological Tumor Grade of Breast Cancer in Western China: An Epidemiological Multicenter Study of 8619 Female Patients.
Zheng K, Tan JX, Li F, Li HY, Zeng XH, Ma BL, Ou JH, Li H, Yang SS, Jiang AM, Ni Q, Liu JL, Liu JP, Zheng H, Yue-Yang, Ling R, He JJ, Li ZG, Zeng J, Zou TN, Jiang J, Song ZJ, Liu QL, Ren GS. Zheng K, et al. Among authors: jiang j, jiang am. Transl Oncol. 2018 Aug;11(4):1023-1033. doi: 10.1016/j.tranon.2018.06.005. Epub 2018 Jul 3. Transl Oncol. 2018. PMID: 29982100 Free PMC article.
Predictors of internal mammary lymph nodes (IMLN) metastasis and disease-free survival comparison between IMLN-positive and IMLN-negative breast cancer patients: Results from Western China Clinical Cooperation Group (WCCCG) database (CONSORT).
Wang K, Zhang X, Zheng K, Yin XD, Xing L, Zhang AJ, Shi Y, Kong LQ, Li F, Ma BL, Li H, Liu JP, Jiang J, Ren GS, Li HY. Wang K, et al. Among authors: jiang j. Medicine (Baltimore). 2018 Jul;97(28):e11296. doi: 10.1097/MD.0000000000011296. Medicine (Baltimore). 2018. PMID: 29995764 Free PMC article.
Clinicopathologic and Prognostic Significance of Body Mass Index (BMI) among Breast Cancer Patients in Western China: A Retrospective Multicenter Cohort Based on Western China Clinical Cooperation Group (WCCCG).
Wang K, Wu YT, Zhang X, Chen L, Zhu WM, Zhang AJ, Zheng K, Yin XD, Li F, Kong LQ, Ma BL, Li H, Liu JP, Jiang J, Li ZY, Shi Y, Ren GS, Li HY. Wang K, et al. Among authors: jiang j. Biomed Res Int. 2019 Apr 18;2019:3692093. doi: 10.1155/2019/3692093. eCollection 2019. Biomed Res Int. 2019. PMID: 31119166 Free PMC article.
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.
Li JY, Jing R, Wei H, Wang M, Xiaowei Q, Liu H, Jian L, Ou JH, Jiang WH, Tian FG, Sheng Y, Li HY, Xu H, Zhang RS, Guan AH, Liu K, Jiang HC, Ren Y, He JJ, Huang W, Liao N, Cai X, Ming J, Ling R, Xu Y, Hu CY, Zhang J, Guo B, Ouyang L, Shuai P, Liu Z, Zhong L, Zeng Z, Zhang T, Xuan Z, Tan X, Liang J, Pan Q, Chen L, Zhang F, Fan LJ, Zhang Y, Yang X, BoLi J, Chen C, Jiang J. Li JY, et al. Among authors: jiang wh, jiang hc, jiang j. Int J Cancer. 2019 Jan 15;144(2):281-289. doi: 10.1002/ijc.31601. Epub 2018 Nov 8. Int J Cancer. 2019. PMID: 29752822
Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.
Wei H, Wang M, Ou J, Jiang W, Tian F, Sheng Y, Li H, Xu H, Zhang R, Guan A, Wang C, Jiang H, Ren Y, He J, Liu J, Huang W, Liao N, Cai X, Ming J, Ling R, Xu Y, Hu C, Zhang J, Guo B, Ouyang L, Shuai P, Liu Z, Zhong L, Jing R, Zeng Z, Zhang M, Zhang T, Xuan Z, Tan X, Liang J, Pan Q, Chen L, Zhang F, Fan L, Zhang Y, Yang X, Li J, Chen C, Jiang J. Wei H, et al. Among authors: jiang h, jiang w, jiang j. Oncol Lett. 2018 Jun;15(6):9420-9428. doi: 10.3892/ol.2018.8538. Epub 2018 Apr 18. Oncol Lett. 2018. PMID: 29805665 Free PMC article.
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial.
Li J, Yu K, Pang D, Wang C, Jiang J, Yang S, Liu Y, Fu P, Sheng Y, Zhang G, Cao Y, He Q, Cui S, Wang X, Ren G, Li X, Yu S, Liu P, Qu X, Tang J, Wang O, Fan Z, Jiang G, Zhang J, Wang J, Zhang H, Wang S, Zhang J, Jin F, Rao N, Ma B, He P, Xu B, Zhuang Z, Wang J, Sun Q, Guo X, Mo M, Shao Z; CBCSG010 Study Group. Li J, et al. Among authors: jiang g, jiang j. J Clin Oncol. 2020 Jun 1;38(16):1774-1784. doi: 10.1200/JCO.19.02474. Epub 2020 Apr 10. J Clin Oncol. 2020. PMID: 32275467 Free PMC article. Clinical Trial.
27,971 results
You have reached the last available page of results. Please see the User Guide for more information.